Delivery Order SPE2DB24D1021-SPE2DB25FEZHX
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $15,223.20 to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Lyrica 100 mg capsules (90 count). This non-set-aside, competitively awarded contract features firm fixed pricing and maintains an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lyrica 50 mg capsules (90-count units) at a ceiling value of $1,182.32. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a delivery order, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lyrica 200 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $3,427.94. This non-set-aside award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 billion and extending through December 2026. The delivery is scheduled for completion by August 12,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,550.74 for 90 capsules of Lyrica 100 mg on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lyrica 100 mg capsules (90-count units) under a firm fixed-price contract valued at $17,255.62. The delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitive, non-set-aside award to support federal pharmaceutical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Lyrica 100 mg capsules (90-count) with a ceiling value of $1,213.60. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded, non-set-aside contract. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $2,336.03 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Lyrica 100 mg capsules (90-count units). This competitively awarded contract utilizes firm fixed pricing and is classified as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,127.48 to AmerisourceBergen Drug Corp for 90 capsules of Lyrica 100 mg on August 6, 2025, with completion scheduled for August 7, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The delivery order will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a contract value of $3,157.69. This non-set-aside, competitively awarded delivery order carries a firm fixed price and is scheduled for completion by September 16, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lyrica 100 mg capsules (90-count units) with a ceiling value of $1,853.49. This firm fixed-price delivery order, which is set to be completed by September 10, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is non-competitive and issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZHXDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,772.13 to AmerisourceBergen Drug Corp for the supply of Lyrica 25 mg capsules (90-count units). This non-set-aside, firm fixed price contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location in Conshohocken, PA 19428. This delivery order represents a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to military healthcare programs and other federal healthcare systems worldwide. Lyrica, a neurological treatment medication, falls within the broad spectrum of pharmaceutical products covered under this strategic partnership, which also encompasses specialty medications, vaccines, and medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/6/25 |